While truncating CDK12 germline variants are very rare, the CDK12 c.1047-2A>G splice variant has recently been reported to occur quite commonly in Tatars where it has been found in some 5% of breast cancer patients and was associated with an about 10-fold increased breast cancer risk (6). This evidence concerns the gene CDK12 and breast carcinoma.